2 / 26
Page 34
Breast Cancer 2017
Day 1 June 15, 2017
Sessions
Breast Cancer Therapy, Prevention and Management | Breast Cancer- Present Perspective |
Breast Cancer Nursing
Session Chair
Steven M Hill
Tulane University School of Medicine, USA
Session Co-chair
Manjeet Rao
University of Texas Health Science Center, USA
Session Introduction
Title:
FOXK2 aberration in breast cancers
Amy Hong Zhang,
University of Texas-M D Anderson Cancer Center, USA
Title:
Circadian/melatonin disruption by dim light at night drives human epithelial breast
cancer to a metastatic phenotype
Steven M. Hill,
Tulane University School of Medicine, USA
Title:
The impact of Nolvadex to generic tamoxifen switch on side effects and patient
compliance in hormone receptor positive breast cancer patients
Bashar Zeidan,
Royal Hampshire County Hospital, UK
Title:
Adverse effects of non-hormonal pharmacological interventions in breast cancer
survivors, suffering from hot flashes: A systematic review and meta-analysis
Jill Brook Hervik,
Vestfold Hospital Trust, Norway
Title:
Volkmann’s breast operation (modified radical mastectomy) and its value in modern
treatment of breast cancer
Valerijus Ostapenko,
National Cancer Institute, Lithuania
Title:
The use of high dose estrogens for the treatment of breast cancer
Carole Verhoeven,
Pantarhei Oncology BV, The Netherlands
Title:
Exclusive self-destruction of triple negative breast cancer cells
Cohen-Armon,
Tel-Aviv University, Israel
Title:
A functional cross-talk between GPER and IGF1/IGF1R signaling drives breast tumor
angiogenesis via activation of the HIF-1
α
/VEGF transduction pathway
Ernestina Marianna De Francesco,
University of Manchester, UK
Title:
FoxM1 inhibition: A novel therapeutic avenue to treat breast cancers
Manjeet Rao,
University of Texas Health Science Center, USA
Title:
The effect of Internet-based breast cancer patient’s pathway on breast cancer patients’
empowering process
Anne Ryhanen,
The University of Turku, Finland
Title:
Relationships among body mass index, systemic immune-inflammation index and
luminal subtype in the resistance to endocrine therapy of breast cancer
Qingxia Li,
Hebei General Hospital, China